Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

Cambrex Facility Completes FDA Inspection



By Kristin Brooks



Published December 17, 2013
Related Searches: API api manufacturing Manufacturing GMP
Cambrex Corp. has successfully completed an FDA inspection of its API manufacturing facility in Charles City, IA. The inspection found the site to be compliant with GMP principles and guidelines, with no Form 483 observations issued. The FDA inspected the facility from July 31 to August 2, 2013.
 
Joe Nettleton, Cambrex’ vice president operations and Charles City site director, said, "We are very pleased with the results of this latest FDA inspection, which further strengthens our track record of outstanding regulatory compliance. We commit significant resources and work diligently to maintain high quality standards and continuously improve quality platforms within Cambrex.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On